Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MC167B: Pilot Study Investigating the Utility of 18F-DOPA-PET in the Treatment of Recurrent High-grade Glioma

NCT03242824 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03242824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03242824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MC167B: Pilot Study Investigating the Utility of 18F-DOPA-PET in the Treatment of Recurrent High-grade Glioma
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Completed
Start date
September 29, 2017
Completion date
June 16, 2021
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioma